Israel Patients File $1.15 Billion Suit Against GSK Israel, Perrigo
This article was originally published in PharmAsia News
Executive Summary
A $1.15 billion class-action lawsuit was filed In Israel against GlaxoSmithKline Israel and U.S.-based Perrigo for 14 patients alleging the formula for their drug had been changed mid-course without notice.